Table 6 Mid-term outcomes. Values are n (%) unless otherwise specified
From: Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty?
SLE | Control | P value | |
|---|---|---|---|
HHS | 89.56 | 90.16 | 0.6453 |
SF-12 | 48.91 | 52.38 | 0.006 |
DVT | 0 | 0 | > 0.9999 |
PE | 0 | 0 | > 0.9999 |
Dislocation | 4 (8.89) | 2 (4.44) | 0.6766 |
Infection | 0 | 0 | > 0.9999 |
Periprosthetic fracture | 0 | 0 | > 0.9999 |
Revision | 0 | 0 | > 0.9999 |
Aseptic loosening | 0 | 0 | > 0.9999 |